Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.049 | 0.7 |